Get the app!
Back to Trades
Total Value
$NaN
Filing Date
Apr 23, 2026
1 transactions

Trade Summary

On Apr 15, 2026, Guillemette Gilles, Director, reported $NaN of IMMUCELL CORP /DE/ (ICCC) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Company Name
IMMUCELL CORP /DE/
Ticker Symbol
ICCC
CIK
0000811641

Insider Information

Role
Director
Location
PORTLAND, ME

Filing Details

Filing Date
Apr 23, 2026
Transaction Date
Apr 15, 2026
Accession Number
0001437749-26-013118
Form Type
3

Want live alerts when Guillemette Gilles trades again?

Download Insider Trades to track ICCC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)The stock option vests as follows: 5,966 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 5,967 shares becoming exercisable on April 15, 2029.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.